Literature DB >> 32726778

Glycogen Synthase Kinase-3 Signaling in Acute Kidney Injury.

Abeda Jamadar1,2, Reena Rao3,4.   

Abstract

Acute kidney injury (AKI) is a common clinical syndrome that involves renal tubular epithelial cell death and leads to acute decline in renal function. Improper tubular regeneration following AKI often leads to CKD. We discuss the role of a serine/threonine protein kinase called glycogen synthase kinase-3 (GSK3) in renal tubular injury and renal fibrosis. We also highlight the importance of GSK3 as a potential drug target in AKI patients and molecular mechanisms promoting tissue regeneration.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Acute kidney injury; Apoptosis; Glycogen synthase kinase-3; Ischemia/reperfusion; Regeneration; Renal fibrosis; TDZD-8

Year:  2020        PMID: 32726778      PMCID: PMC7708525          DOI: 10.1159/000509354

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  17 in total

Review 1.  Cellular and Molecular Mechanisms of AKI.

Authors:  Anupam Agarwal; Zheng Dong; Raymond Harris; Patrick Murray; Samir M Parikh; Mitchell H Rosner; John A Kellum; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2016-02-09       Impact factor: 10.121

2.  Nephroprotective effect of GSK-3β inhibition by lithium ions and δ-opioid receptor agonist dalargin on gentamicin-induced nephrotoxicity.

Authors:  E Y Plotnikov; O A Grebenchikov; V A Babenko; I B Pevzner; L D Zorova; V V Likhvantsev; D B Zorov
Journal:  Toxicol Lett       Date:  2013-05-04       Impact factor: 4.372

Review 3.  Glycogen Synthase Kinase 3: A Kinase for All Pathways?

Authors:  Prital Patel; James R Woodgett
Journal:  Curr Top Dev Biol       Date:  2016-12-28       Impact factor: 4.897

4.  First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease.

Authors:  Ana Martinez; Mercedes Alonso; Ana Castro; Concepción Pérez; Francisco J Moreno
Journal:  J Med Chem       Date:  2002-03-14       Impact factor: 7.446

5.  GSK3beta promotes apoptosis after renal ischemic injury.

Authors:  Zhiyong Wang; Andrea Havasi; Jonathan Gall; Ramon Bonegio; Zhijian Li; Haiping Mao; John H Schwartz; Steven C Borkan
Journal:  J Am Soc Nephrol       Date:  2010-01-21       Impact factor: 10.121

6.  The role of mitochondria in oxidative and nitrosative stress during ischemia/reperfusion in the rat kidney.

Authors:  E Y Plotnikov; A V Kazachenko; M Y Vyssokikh; A K Vasileva; D V Tcvirkun; N K Isaev; V I Kirpatovsky; D B Zorov
Journal:  Kidney Int       Date:  2007-10-03       Impact factor: 10.612

7.  Inhibiting glycogen synthase kinase-3 reduces endotoxaemic acute renal failure by down-regulating inflammation and renal cell apoptosis.

Authors:  Y Wang; W C Huang; C Y Wang; C C Tsai; C L Chen; Y T Chang; J I Kai; C F Lin
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

8.  Specific deletion of glycogen synthase kinase-3β in the renal proximal tubule protects against acute nephrotoxic injury in mice.

Authors:  Christiana Howard; Shixin Tao; Hai-Chun Yang; Agnes B Fogo; James R Woodgett; Raymond C Harris; Reena Rao
Journal:  Kidney Int       Date:  2012-07-11       Impact factor: 10.612

9.  GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS.

Authors:  Hagit Eldar-Finkelman; Ana Martinez
Journal:  Front Mol Neurosci       Date:  2011-10-31       Impact factor: 5.639

10.  Effects of chronic alcohol exposure on ischemia-reperfusion-induced acute kidney injury in mice: the role of β-arrestin 2 and glycogen synthase kinase 3.

Authors:  Lihua Wang; Yifei Zhu; Lili Wang; Jingjing Hou; Yongning Gao; Lei Shen; Jingyu Zhang
Journal:  Exp Mol Med       Date:  2017-06-23       Impact factor: 8.718

View more
  1 in total

1.  The Suppression of Pin1-Alleviated Oxidative Stress through the p38 MAPK Pathway in Ischemia- and Reperfusion-Induced Acute Kidney Injury.

Authors:  Xiaojie Zhao; Dan Wang; Shanshan Wan; Xiuheng Liu; Wei Wang; Lei Wang
Journal:  Oxid Med Cell Longev       Date:  2021-07-30       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.